The Irish High Court has sanctioned Avadel Pharmaceuticals' scheme of arrangement without modification, allowing Alkermes to acquire Avadel's entire issued share capital. The transaction is expected to close on February 12, 2026, with trading of Avadel shares on Nasdaq halting on February 11, 2026.

State Street Global Advisors & Affiliates disclosed a purchase of 621 ordinary shares in Avadel Pharmaceuticals plc on January 15, 2026, bringing their total holding to 2,298,069 shares representing 2.36% of the company. The disclosure was filed under Irish Takeover Panel Rule 8.3.

Avadel Pharmaceuticals shareholders have approved the proposed acquisition by Alkermes plc through a scheme of arrangement. The approval was overwhelming, with 97.41% of votes cast in favor at the scheme meeting and 96.53% approval at the extraordinary general meeting. The transaction is expected to proceed pending satisfaction of remaining condi...

State Street Global Advisors & Affiliates disclosed a dealing in Avadel Pharmaceuticals plc on December 23, 2025, purchasing 2,433 shares at $21.54 per unit while selling 263 shares at the same price. The entity now holds 2,292,882 shares representing 2.35% of the company's ordinary shares.

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies involved in merger and acquisition transactions.